ReviewTherapeutic advances in rare disease

Miglustat: a first-in-class enzyme stabilizer for cipaglucosidase alfa for the treatment of late-onset Pompe disease.

Robert J Hopkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.